GIST targeted NGS panel

Alphabetical Test listing

GIST targeted NGS panel-Pathology add-on

  
GIST targeted NGS panel
  
Pathology add-on
  
FOCUS
  
Colorectal cancer NGS panel
Gastrointestinal cancer NGS panel
Hot spot mutations
Next Generation Sequencing
Oncomine focus assay
  
  • KIT
  • PDGFRA
  • BRAF
  

Next Generation Sequencing (NGS) for the detection of alterations in solid tumors is critical for cancer care as these findings can direct the optimal use of targeted therapies for patients.

  

If blocks more than 5 years old are submitted for testing, extraction will be attempted, but if insufficient RNA/DNA is retrieved, testing will be cancelled

  
Tumor tissue
  

Formalin-fixed paraffin-embedded (FFPE) tissue block

  

Cytology slide

  

Molecular Medicare billing request

Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medical billing request form along with the sample.

  • Complete and submit the form to notify us of the need for Allina Health Laboratory to bill insurance for Molecular testing performed
  • All information requested is required in order for your request to be completed
  

Ambient

  
  • Improper label (unlabeled or mislabeled)
  • Wrong container (anticoagulant or solution)
  • Improper blood/anticoagulant ratio
  • Delay in transport
  • Improper storage
  • Inappropriate timing of collection
  • Interfering substances
  • Leaking container
  • Slides broken beyond repair
  
AHL - Molecular Diagnostics: D
  
Varies
  
10 business days
  

Next Generation Sequencing

  

No variations detected

  
This test may require preauthorization from the insurance provider. Check the payer guidelines and, if needed, obtain the pre-authorization prior to sample collection.
  
81272 - KIT NGS
81314 - PDGFRA NGS
81210 - BRAF NGS
  
Yes
  
  
12/08/2020
  
04/01/2021